- cafead   Feb 17, 2021 at 11:42: PM
via Exact Sciences has bolstered its play for the colorectal cancer residual disease and recurrence market by striking a deal to buy Ashion Analytics from The Translational Genomics Research Institute (TGen).
article source
article source